Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Sep 15;140(11):1191-1192.
doi: 10.1182/blood.2022017725.

Diffuse myocardial fibrosis as an SCD biomarker

Affiliations
Editorial

Diffuse myocardial fibrosis as an SCD biomarker

Swee Lay Thein et al. Blood. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: The authors declare no competing financial interests.

Comment on

References

    1. Niss O, Detterich J, Wood JC, et al. . Early initiation of disease-modifying therapy can impede or prevent diffuse myocardial fibrosis in sickle cell anemia. Blood. 2022;140(11):1322-1324. - PMC - PubMed
    1. Hamideh D, Alvarez O. Sickle cell disease related mortality in the United States (1999-2009). Pediatr Blood Cancer. 2013;60(9):1482-1486. - PubMed
    1. Niss O, Quinn CT, Lane A, et al. . Cardiomyopathy with restrictive physiology in sickle cell disease. JACC Cardiovasc Imaging. 2016;9(3):243-252. - PMC - PubMed
    1. Sachdev V, Rosing DR, Thein SL. Cardiovascular complications of sickle cell disease. Trends Cardiovasc Med. 2021;31(3):187-193. - PMC - PubMed
    1. Niss O, Fleck R, Makue F, et al. . Association between diffuse myocardial fibrosis and diastolic dysfunction in sickle cell anemia. Blood. 2017;130(2):205-213. - PMC - PubMed